new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Wyeth Llc
Wyeth
Wyeth Holdings Corporation
Wyeth Holdings Llc
Wyeth Holdings Corporation_20100128
Wyeth Five Giralda Farms
Wyeth Farma S a
Wyeth A New Jersey Corporation
Wyeth And Etex Corp
Wyeth And Fidia Advanced Biopolymers S r l
Wyeth Corporation
Wyeth Holdings
Wyeth_20100121
Wyeth_20100128
Wyeth_20100114
Wyeth_20100107
Wyeth Llp
Wyeth Madison New Jersey
Wyeth Llc_20131212
  

Wyeth patents

Recent patent applications related to Wyeth. Wyeth is listed as an Agent/Assignee. Note: Wyeth may have other listings under different names/spellings. We're not affiliated with Wyeth, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "W" | Wyeth-related inventors




Date Wyeth patents (updated weekly) - BOOKMARK this page
07/02/15Chewable tablet containing phenylephrine
02/05/15Multivalent pneumococcal polysaccharide-protein conjugate composition
09/25/14Local vascular delivery of trichostatin a alone or in combination with sirolimus to prevent restenosis following vascular injury
06/19/14Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine
03/20/14Peripheral opioid receptor antagonists and uses thereof
10/31/13Neutralizing antibodies against gdf-8 and uses therefor
07/25/13Portable moist heat system
01/10/13Peripheral opioid receptor antagonists and uses thereof
12/13/12Peripheral opioid receptor antagonists and uses thereof
11/01/12Tigecycline formulations
10/18/12Composition and treating hemorrhoids and/or anorectal disorders
05/31/12Hydroxyethyl starch-containing polypeptide compositions
03/08/12Dry powder compound formulations and uses thereof
01/05/12Formulation comprising bioactive agents and using same
11/10/11Antibodies against human il-22 and uses therefor
08/04/11Novel immunogenic compositions for the prevention and treatment of meningococcal disease
07/07/11Protein hydrolysate excipients
06/16/11Humanized antibodies that recognize beta amyloid peptide
05/05/11Benzimidazole acetic acids exhibiting crth2 receptor antagonism and uses thereof
03/24/11Nucleic acid and amino acid sequences relating to staphylococcus epidermidis for diagnostics and therapeutics
03/24/11Multivalent pneumococcal polysaccharide-protein conjugate composition
02/17/11Platelet glycoprotein ib alpha variant fusion polypeptides and methods of use thereof
02/17/111,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylate nuclear receptor inhibitors
02/10/11Immunoglobulin fusion protein formulations
01/27/11Antibody inhibitors of gdf-8 and uses thereof
01/27/11Nucleic acid and amino acid sequences relating to staphylococcus epidermidis for diagnostics and therapeutics
12/16/10Multivalent pneumococcal polysaccharide-protein conjugate composition
12/09/10Swine vaccination system
12/02/10Modified and stabilized gdf propeptides and uses thereof
11/04/10Cci-779 derivatives and methods of making same
10/21/10Ion channel modulators
10/14/10Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4
10/07/10Novel molecules of the pyrin/nbs/lrr protein family and uses thereof
09/16/10Immunogenic compositions and methods for treating and preventing animal infections
09/09/10Circovirus sequences associated with piglet weight loss disease (pwd)
09/02/10Circovirus sequences associated with piglet weight loss disease (pwd)
09/02/10Circovirus sequences associated with piglet weight loss disease (pwd)
08/26/10Circovirus sequences associated with piglet weight loss disease (pwd)
08/26/10Polymorphs of n2-(1,1'-biphenyl-4-ylcarbonyl)-n1-[2-(4-fluorophenyl)-1,1-dimethylethyl]-l-alpha-glutamine
08/19/10Circovirus sequence associated with piglet weight loss disease (pwd)
08/12/10Circovirus sequences associated with piglet weight loss disease (pwd)
08/05/10Immunophilin ligands and methods for modulating immunophilin and calcium channel activity
08/05/10Process for preparing quinoline compounds and products obtained therefrom
07/29/10Circovirus sequences associated with piglet weight loss disease (pwd)
07/29/10Circovirus sequences associated with piglet weight loss disease (pwd)
07/29/10Circovirus sequences associated with piglet weight loss disease (pwd)
07/29/10Circovirus sequences associated with piglet weight loss disease (pwd)
07/29/10Circovirus sequences associated with piglet weight loss disease (pwd)
07/29/10Circovirus sequences associated with piglet weight loss disease (pwd)
07/08/10Methods for purification of single domain antigen binding molecules
07/08/10Circovirus sequences associated with piglet weight loss disease (pwd)
07/08/10Humanized anti-5t4 antibodies and anti-5t4/calicheamicin conjugates
07/01/10Circovirus sequences associated with piglet weight loss disease (pwd)
06/24/10Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4
06/24/10Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4
06/24/10Benzoxathiine and benzoxathiole derivatives and uses thereof
06/10/10Humanized anti-rage antibody
06/03/10Formulations of single domain antigen binding molecules
06/03/10Biaryl sulfonamides and methods for using same
05/20/10Single chain antibody library design
05/13/10Multicomponent immunogenic composition for the prevention of beta-hemolytic streptococcal (bhs) disease
05/13/10Compatible display vector systems
05/13/10Triazine derivatives as inhibitors of phosphodiesterases
05/13/10Imidazo[5,1-c][1,2,4]benzotriazine derivatives as inhibitors of phosphodiesterases
05/13/10Quinoxaline-based lxr modulators
Patent Packs
05/13/101-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands
05/13/10Peripheral opioid receptor antagonists and uses thereof
05/06/10Compatible display vector systems
05/06/10Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4
05/06/10Liquid formulations of phospholipase enzyme inhibitors
05/06/10Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine
05/06/10Purification of acidic proteins using ceramic hydroxyapatite chromatography
04/22/10Peripheral opioid receptor antagonists and uses thereof
04/15/10Semi-solid formulations of phospholipase enzyme inhibitors
04/08/10Benzimidazole anthelmintic compositions
04/01/10Recombinant lubricin molecules and uses thereof
04/01/10Src activation for determining cancer prognosis and as a target for cancer therapy
03/25/10Recombinant lubricin molecules and uses thereof
03/18/104-aryloxyquinolin-2(1h)-ones as mtor kinase and pi3 kinase inhibitors, for use as anti-cancer agents
03/18/10Pharmaceutical compositions of an src kinase inhibitor and an aromatase inhibitor
Patent Packs
03/18/10Liquid formulations of phospholipase enzyme inhibitors
03/11/103-substituted-1h-indole, 3-substituted-1h-pyrrolo[2,3-b]pyridine and 3-substituted-1h-pyrrolo[3,2-b]pyridine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
03/11/10Mycoplasma hyopneumoniae bacterin vaccine
03/11/10Delayed release formulations for oral administration of a polypeptide therapeutic agent and methods of using same
03/11/10Protein kinase c zeta as a drug target for arthritis and other inflammatory diseases
03/11/10Bicyclic and tricyclic substituted 6-methylidene carbapenems as broad spectrum beta-lactamase inhibitors
03/11/10Hydantoins having rnase modulatory activity
03/04/10Composition and treating hemorrhoids and/or anorectal disorders
02/25/10Follistatin domain containing proteins
02/25/10Immunological composition
02/18/10Pyrrolo[4,3,2-de]quinolin-8-amine compounds and methods of their preparation and use
02/18/10Lyophilization above collapse
02/11/10Tigecycline formulations
02/11/10Process for the preparation of 2,4-dichloro-7h-pyrrolo[2,3h]quinazoline
02/04/10Methods of upmodulating adaptive immune response using anti-pd1 antibodies
02/04/10Fermentation and purification of actinomadura chromoprotein and related species
02/04/10Oligonucleotide arrays to monitor gene expression and methods for making and using same
02/04/10Aryl sulfamide derivatives and methods of their use
02/04/10Bridged, bicyclic heterocyclic or spiro bicyclic heterocyclic derivatives of pyrazolo[1, 5-a]pyrimidines, methods for preparation and uses thereof
02/04/104-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (cml)
01/28/10Gasp1: a follistatin domain containing protein
01/28/10Humanized anti-5t4 antibodies and anti-5t4/calicheamicin conjugates
01/28/10Biosynthetic gene cluster for the production of a complex polyketide
01/21/104-phenoxy-6-aryl-1h-pyrazolo[3,4-d]pyrimidine and n-aryl-6-aryl-1h-pyrazolo[3,4-d]pyrimidin-4-amine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
01/21/10Methods of using antibodies against human il-22
01/21/10Device and controlling insects
01/21/10Indole acetic acids exhibiting crth2 receptor antagonism and uses thereof
01/21/10Methods of preparing polymorphic form a of bazedoxifene acetate
01/21/10Methods of converting polymorphic form b of bazedoxifene acetate to polymorphic form a of bazedoxifene acetate
01/21/10Methods for the preparation of azole compounds
Social Network Patent Pack
01/21/10Production of chirally pure amino alcohol intermediates, derivatives thereof, and uses thereof
01/14/10Glutamate aggrecanase inhibitors
01/07/10(2-aryl-7h-pyrrolo[2,3-d]pyrimidin-4-yl)morpholine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
12/31/09Lyophilization cycle robustness strategy
12/31/09Dual adhesive technology
12/31/09Methods of detection and quantification of host cell dna contamination of purified proteins
12/31/09Gene expression profiles associated with asthma exacerbation attacks
12/31/09Combination product of receptor tyrosine kinase inhibitor and fatty acid synthase inhibitor for treating cancer
12/31/095-aryl indan-1-one and analogs useful as progesterone receptor modulators
12/31/09Piperazine metabotropic glutamate receptor 5 (mglur5) negative allosteric modulators for anxiety/depression
Patent Packs
12/31/09Thiazolo naphthyl acids
12/31/09Enantiomers of o-desmethyl venlafaxine
12/24/09Compositions and methods of use of orf 554 from beta hemolytic streptococcal strains
12/24/09Compositions and methods of use of orf1358 from beta-hemolytic streptococcal strains
12/24/09Thiazolyl-and oxazolyl-isoquinolinones and methods for using them
12/24/091-substituted-3-(naphthalen-1-ylsulfonyl)-5-(piperazin-1-yl)-1h-indazole compounds as 5-hydroxytryptamine-6 ligands
12/17/093-substituted-1h-indole compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
12/17/09Methods and compositions for selective inhibition of ligand binding to the lectin-like receptor for oxidized low density lipoprotein (lox-1)
12/17/09Fluorescence-based assay for monoacylglycerol lipase compatible with inhibitor screening
12/17/09Antineoplastic combinations containing hki-272 and vinorelbine
12/17/09Processes for the convergent synthesis of calicheamicin derivatives
12/10/09Triazine compounds as pi3 kinase and mtor inhibitors
12/10/09Tanaproget derivatives, metabolites, and uses thereof
12/10/09Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same
12/03/09Antineoplastic combinations with mtor inhibitor, trastuzumab, and/or hki-272
12/03/09Methods of treatment utilizing binding proteins of the interleukin-21 receptor
12/03/093-substituted-1h-pyrrolo[2,3-b]pyridine and 3-substituted-1h-pyrrolo[3,2-b]pyridine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
11/26/09Triazine compounds as pi3 kinase and mtor inhibitors
11/26/09Heteroaryl ethers and processes for their preparation
11/19/09Method of delivering a hair care benefit
11/19/09Method of delivering a skin benefit
11/19/09Portable moist heat system
11/12/09Methods for modulating bladder function
11/12/09Cyclothiocarbamate derivatives as progesterone receptor modulators
11/05/09Methods for treating inflammation
11/05/09Il-13 binding agents
11/05/09Pharmaceutical polish formulations
10/29/092-aryl- and 2-heteroarylthiazolyl compounds, methods for their preparation and use thereof
10/29/092-aryl-and 2-heteroarylthiazolyl compounds, methods for their preparation and use thereof
10/29/09Crystal structure of human factor viii and uses thereof
Patent Packs
10/22/09Methods for diagnosing and treating systemic lupus erythematosus disease and compositions thereof
10/22/093-cyanoquinolines, methods for preparation and use as insulin-like growth factor inhibitors
10/15/09Therapeutic compositions and methods
10/08/09Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
10/08/09G-protein coupled receptor and uses therefor
10/01/09Novel rat voltage-gated potassium channel
10/01/09Serum-free vero cell banking process
09/24/09Rapamycin analogues and the uses thereof in the treatment of neurological, proliferative, and inflammatory disorders
09/24/091-aryl-or 1- alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
09/24/09Pharmaceutical formulations of an anhydrate crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol
09/17/09Type 2 cytokine receptor and nucleic acids encoding same
09/17/09Multivalent pneumococcal polysaccharide-protein conjugate composition
09/10/09Novel modulating bone-related activity
09/10/09Avian embryo particulate biomass for the production of virus antigens
09/10/09Biphenyl vasopressin agonists
09/10/097h-pyrrolo[2,3-h]quinazoline compounds, their use as mtor kinase and pi3 kinase inhibitors, and their synthesis
09/10/09Substituted n-heterocycle derivatives and methods of their use
09/10/09Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof
09/03/09Nutritional formulation
09/03/09Cell-based methods for detecting and/or measuring bmp-12-related protein activity
Social Network Patent Pack
09/03/09Systems and methods for protein production
09/03/09Trifluoromethyl-containing phenylsulfonamide beta amyloid inhibitors
08/27/09Mammalian expression systems
08/27/09Soluble clca-1 and antagonists to clca-1
08/27/09Fxr agonists for treating vitamin d associated diseases
08/27/09Serotonergic agents
08/27/09Selective acylation of 4-substituted-1,3-phenylenediamine
08/20/09Methods for using rapamycin analogues in the treatment of neurological disorders
08/20/09Use of rxr agonists for the treatment of osteoarthritis
08/13/09Expression of orphan gpr64 in inflammatory diseases
08/13/09Novel immunogenic compositions for the prevention and treatment of meningococcal disease
08/13/09Rapamycin analogues and the uses thereof in the treatment of neurological disorders
08/06/09Substituted benzo[d][1,3]oxazin-2(4h)-ones and related derivatives and their uses for modulating the progesterone receptor
07/30/09[a]-fused indole compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
07/30/091h-pyrazolo[3,4-d]pyrimidine, purine, 7h-purin-8(9h)-one, 3h-[1,2,3]triazolo[4,5-d]pyrimidine, and thieno[3,2-d]pyrimidine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
07/30/09Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by vla-4
07/23/09Ephrin and eph receptor agonists for modulation of bone formation and resorption
07/16/09Compositions containing o-sulfate and o-phosphate containing aryl sulfonamide derivatives useful as beta-amyloid inhibitors
07/16/093h-[1,2,3]triazolo[4,5-d]pyrimidine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
07/09/09Methods for packaging propagation-defective vesicular stomatitis virus vectors
Social Network Patent Pack
07/09/09Genetically modified attenuated vesicular stomatitis virus, compositions and methods of use thereof
07/09/092-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
07/09/09Maleate salts of (e)-n--4-(dimethylamino)-2-butenamide and crystalline forms thereof
07/09/09Pharmaceutical suspension composition
07/09/09Cloning genes from streptomyces cyaneogriseus subsp. noncyanogenus for biosynthesis of antibiotics and methods of use
07/02/09Treatment of sleep disturbances
06/25/09Methods for packaging propagation-defective vesicular stomatitis virus vectors using a stable cell line that expresses g protein
06/25/09Methods and compositions for immunizing pigs against porcine circovirus
06/25/09Circovirus sequences associated with piglet weight loss disease (pwd)
06/25/09Fxr agonists for the treatment of nonalcoholic fatty liver and cholesterol gallstone diseases
06/18/09Microemulsions for pharmaceutical compositions
06/18/09Assessment of asthma and allergen-dependent gene expression
06/18/09Assays and methods for evaluating multimeric complexes
06/18/09Use of fibrous tissue inducing proteins for hernia repair
06/18/09Compositions and methods for diagnosing and treating asthma or other allergic or inflammatory diseases
06/18/09Methods for the preparation of hydroxy-substituted aryl sulfamide compounds
06/11/09Antibody to gdf8 and uses thereof
06/11/09Pyrrolo[3,2-d]pyrimidine compounds and their use as pi3 kinase and mtor kinase inhibitors
06/04/09Nested pcr-based specific genotyping of the fc gamma receptor iiia gene
06/04/09Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor
06/04/09Thioamide derivatives as progesterone receptor modulators
06/04/09Pyrido[3,2-e]pyrazines, process for preparing the same, and their use as inhibitors of phosphodiesterase 10
06/04/09Aryl and heteroaryl fused imidazo[1,5-a]pyrazines as inhibitors of phosphodiesterase 10
06/04/09Purification of progesterone receptor modulators
05/28/09Hbm variants that modulate bone mass and lipid levels
05/28/09Compositions and methods of treating dyslipidemia
05/28/091,4,5,6-tetrahydro -pyrrolo[2,3-d]azepines and -imidazo[4,5-d]azepines as modulators of nuclear receptor activity
05/28/09Bazedoxifene ascorbate
05/21/09Multivalent pneumococcal polysaccharide-protein conjugate composition
05/21/091,4,5,6,7,8-hexahydro -pyrrolo[2,3-d]azepines and -imidazo[4,5-d]azepines as modulators of nuclear receptor activity
Social Network Patent Pack
05/14/09Alpha-1d calcium channel expressed in atrium
05/07/09Mycoplasma hyopneumoniae avirulent adjuvanted live vaccine
05/07/09Thienopyrimidines, thienopyridines, and pyrrolopyrimidines as b-raf inhibitors
04/30/09Cyclocarbamate derivatives as progesterone receptor modulators
04/30/09Indole acetic acids exhibiting crth2 receptor antagonism and uses thereof
04/23/09Nucleic acid molecule encoding a novel estrogen receptor beta variant
04/23/09Biosynthetic gene cluster for the production of a complex polyketide
04/23/09Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligands
04/23/09Calicheamicin conjugates
04/16/09Color measurements of reconstituted tigecycline and degradant thereof
04/16/09Thienopyrimidine and pyrazolopyrimidine compounds and their use as mtor kinase and pi3 kinase inhibitors
04/16/09Method of identifying compounds that modulate caspase 9 activity via use of a kosmotropic salt
04/16/09Bioadhesive film
04/16/09Phenylaminopropanol derivatives and methods of their use
04/16/09Methods of treating hormone-related conditions using thio-oxindole derivatives
04/16/09Preparation of 7-alkenyl-3 quinolinecarbonitriles via a palladium mediated coupling reaction
04/16/09Tigecycline and methods of preparing intermediates
04/09/09Heterologous prime-boost immunization regimen
04/09/09Phenylaminopropanol derivatives and methods of their use
04/09/09Amino-5,5-diphenylimidazolone derivatives for the inhibition of beta-secretase
04/09/09Chiral synthesis of diazepinoquinolines
04/02/09Actriib fusion polypeptides and uses therefor
04/02/09Methods of treating bone disorders with modulators of axl
04/02/09Actriib fusion polypeptides and uses therefor
04/02/09Rapamycin derivatives and the uses thereof in the treatment of neurological disorders
03/26/09Pyrazolo[5, 1-c] [1,2,4] triazines, methods for preparation and use thereof
03/26/09Dihydrobenzofuranyl alkanamine derivatives and methods for using same
03/26/09Methods for preparing sulfonamide compounds
03/19/09Method of making heat cells comprising exothermic compositions having absorbent gelling material







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Wyeth in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Wyeth with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';